CiteFacts · FDA Drug Shortages · FDA source
Midazolam Hydrochloride Injection
Status
FDA currently lists this ingredient in shortage.
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Presentation | FDA availability field | FDA update |
|---|---|---|---|
| Avet Pharmaceuticals, Inc. | Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 23155-600-41) | Limited Availability | 08/18/2026 |
| Avet Pharmaceuticals, Inc. | Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 23155-601-41) | Available | 08/18/2026 |
| Avet Pharmaceuticals, Inc. | Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 23155-601-42) | Available | 08/18/2026 |
| Fresenius Kabi USA, LLC | Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2 mL (NDC 76045-211-20) | Unavailable | 08/04/2026 |
| Fresenius Kabi USA, LLC | Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-10) | Unavailable | 08/04/2026 |
| Fresenius Kabi USA, LLC | Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-12) | Unavailable | 08/04/2026 |
| Fresenius Kabi USA, LLC | Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-25) | Available | 08/04/2026 |
| Fresenius Kabi USA, LLC | Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-02) | Available | 08/04/2026 |
| Fresenius Kabi USA, LLC | Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-10) | Unavailable | 08/04/2026 |
| Fresenius Kabi USA, LLC | Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-25) | Unavailable | 08/04/2026 |
| Gland Pharma Limited | Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 25021-655-02) | Unavailable | 07/22/2026 |
| Gland Pharma Limited | Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-661-10) | Unavailable | 07/22/2026 |
| Hikma Pharmaceuticals USA, Inc. | Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6056-10) | Available | 08/13/2026 |
| Hikma Pharmaceuticals USA, Inc. | Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6057-25) | Available | 08/13/2026 |
| Hikma Pharmaceuticals USA, Inc. | Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6059-01) | Unavailable | 08/13/2026 |
| Hikma Pharmaceuticals USA, Inc. | Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6060-10) | Available | 08/13/2026 |
| Hikma Pharmaceuticals USA, Inc. | Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6061-25) | Available | 08/13/2026 |
| Hospira, Inc., a Pfizer Company | Midazolam Hydrochloride Preservative Free, Injection, 10 mg/2 mL (5 mg/mL) (NDC 0409-2308-02) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2mL (1 mg/mL) (NDC 0409-2305-17) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Midazolam Hydrochloride Preservative Free, Injection, 5 mg/5 mL (1 mg/mL) (NDC 0409-2305-05) | Limited Availability | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Midazolam Hydrochloride Preservative Free, Injection, 5 mg/mL (5 mg/mL) (NDC 0409-2308-01) | Unavailable | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Midazolam Hydrochloride, Injection, 10 mg/10 mL (1 mg/mL) (NDC 0409-2587-05) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Midazolam Hydrochloride, Injection, 25 mg/5 mL (5 mg/mL) (NDC 0409-2596-03) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Midazolam Hydrochloride, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-2596-05) | Available | 08/07/2026 |
| WG Critical Care | Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-610-10) | Available | 08/17/2026 |
| WG Critical Care | Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-611-10) | Available | 08/17/2026 |
Source facts
Grouped generic ingredient: Midazolam Hydrochloride Injection · 26 package records · Latest FDA row update: 08/18/2026
Therapeutic categories: Anesthesia, Neurology
Dosage forms: Injection
Routes: INTRAMUSCULAR, INTRAVENOUS
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-08-22T15:54:11+00:00. Derived grouping is documented in this record's derivations.